4 Results for "

acanthosis

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "acanthosis" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-131968
CAS No.: 1771691-34-9
Purity:  99.92%
BMS-986202 is a potent, selective and orally active Tyk2 inhibitor that binds to Tyk2 JH2 with an IC50 value of 0.19 nM and a Ki of 0.02 nM. BMS-986202 is remarkably selective over other kinases including Jak family members. BMS-986202 is also a weak inhibitor of CYP2C19 with an IC50 value of 14 μM. BMS-986202 can be used for IL-23-driven acanthosis, anti-CD40-induced colitis, and spontaneous lupus research. BMS-986202 is a de novo deuterium .
loading...
    loading...
Cat. No.: HY-136527
CAS No.: 2460133-35-9
Target:  

ROR Interleukin Related

Research Areas:  

Inflammation/Immunology

BMS-986251 is an orally active and selective RORγt inverse agonist with an EC50 of 12 nM for RORγt GAL4. BMS-986251 inhibits IL-17 with an EC50 of 24 nM in human whole blood assay. BMS-986251 demonstrates robust efficacy in mouse acanthosis and Imiquimod-induced (HY-B0180) models (preclinical models of psoriasis) .
loading...
    loading...
Cat. No.: HY-132195
CAS No.: 2672496-70-5
Target:  

ROR

Research Areas:  

Inflammation/Immunology

RORγt inverse agonist 14 (8e) is a potent, orally active and selective RORγt inverse agonist (EC50 of 2.5 nM) with anti-inflammatory activity. RORγt inverse agonist 14 is used in the study for rheumatoid arthritis and psoriasis .
loading...
    loading...
Cat. No.: HY-122833
CAS No.: 2833703-74-3
Target:  

FGFR

FGFR3-IN-10 is a selective FGFR3 inhibitor that inhibits FGFR3 kinase activity. FGFR3-IN-10 can be used in research related to cancer, systemic sclerosis, fibrosis, pulmonary fibrosis, achondroplasia, lethal dwarfism, severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN), and Muenke syndrome .
loading...
    loading...